List of Excipients in API misoprostol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing misoprostol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | CYTOTEC | misoprostol | 0025-1451 | CELLULOSE, MICROCRYSTALLINE | |
| Pfizer Laboratories Div Pfizer Inc | CYTOTEC | misoprostol | 0025-1451 | HYDROGENATED CASTOR OIL | |
| Pfizer Laboratories Div Pfizer Inc | CYTOTEC | misoprostol | 0025-1451 | HYPROMELLOSE | |
| Apotheca Inc | MISOPROSTOL | misoprostol | 12634-502 | CELLULOSE, MICROCRYSTALLINE | |
| Apotheca Inc | MISOPROSTOL | misoprostol | 12634-502 | HYDROGENATED CASTOR OIL | |
| Apotheca Inc | MISOPROSTOL | misoprostol | 12634-502 | HYPROMELLOSES | |
| GenBioPro Inc | MISOPROSTOL | misoprostol | 43393-020 | CELLULOSE, MICROCRYSTALLINE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing misoprostol
Detailed excipient profiles for misoprostol
Excipient focus: CELLULOSE, MICROCRYSTALLINE
misoprostol drug variants containing CELLULOSE, MICROCRYSTALLINE
misoprostol drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
misoprostol drug variants containing CROSPOVIDONE
misoprostol drug variants not containing CROSPOVIDONE
Excipient focus: HYDROGENATED CASTOR OIL
misoprostol drug variants containing HYDROGENATED CASTOR OIL
misoprostol drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYDROGENATED COTTONSEED OIL
misoprostol drug variants containing HYDROGENATED COTTONSEED OIL
misoprostol drug variants not containing HYDROGENATED COTTONSEED OIL
Excipient focus: HYPROMELLOSE
misoprostol drug variants containing HYPROMELLOSE
misoprostol drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
misoprostol drug variants containing HYPROMELLOSES
misoprostol drug variants not containing HYPROMELLOSES
Excipient focus: SILICON DIOXIDE
misoprostol drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | misoprostol | 42571-253 |
| >Company | >Ingredient | >NDC |
misoprostol drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
misoprostol drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
misoprostol drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
